Małgorzata Geszke-Moritz

Dr. Małgorzata Geszke-Moritz

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Chemical Engineering Journal
Verified
Journal Article
Closed access
MMMichał Moritz
Michał Moritz
MGMałgorzata Geszke-Moritz
Małgorzata Geszke-Moritz

1 November 2016 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MGMałgorzata Geszke-Moritz
Małgorzata Geszke-Moritz
MMMichał Moritz
Michał Moritz

7 September 2024 in Polymers
Verified
Journal Article
Open access
PDF file
MGMałgorzata Geszke-Moritz
Małgorzata Geszke-Moritz
MMMichał Moritz
Michał Moritz
In the last few decades, there has been a growing interest in the use of biodegradable polymeric nanoparticles (BPNPs) as the carriers for various therapeutic agents in drug delivery systems. BPNPs have the potential to improve the efficacy of numerous active agents by facilitating targeted delivery to a desired site in the body. Biodegradable polymers are especially promising nanocarriers for therapeutic substances characterized by poor solubility, instability, rapid metabolism, and rapid system elimination. Such molecules can be efficiently encapsulated and subsequently released from nanoparticles, which greatly improves their stability and bioavailability. Biopolymers seem to be the most suitable candidates to be used as the nanocarriers in various delivery platforms, especially due to their biocompatibility and biodegradability. Other unique properties of the polymeric nanocarriers include low cost, flexibility, stability, minimal side effects, low toxicity, good entrapment potential, and long-term and controlled drug release. An overview summarizing the research results from the last years in the field of the successful fabrication of BPNPs loaded with various therapeutic agents is provided. The possible challenges involving nanoparticle stability under physiological conditions and the possibility of scaling up production while maintaining quality, as well as the future possibilities of employing BPNPs, are also reviewed.

23 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
KJKatarzyna Janda-Milczarek
Katarzyna Janda-Milczarek
IGIzabela Gutowska
Izabela Gutowska
MGMałgorzata Geszke-Moritz
Małgorzata Geszke-Moritz
Karolina JakubczykKarolina Jakubczyk
Karolina Jakubczyk
Natural products are gaining more interest recently, much of which focuses on those derived from medicinal plants. The common chicory (Cichorium intybus L.), of the Astraceae family, is a prime example of this trend. It has been proven to be a feasible source of biologically relevant elements (K, Fe, Ca), vitamins (A, B1, B2, C) as well as bioactive compounds (inulin, sesquiterpene lactones, coumarin derivatives, cichoric acid, phenolic acids), which exert potent pro-health effects on the human organism. It displays choleretic and digestion-promoting, as well as appetite-increasing, anti-inflammatory and antibacterial action, all owing to its varied phytochemical composition. Hence, chicory is used most often to treat gastrointestinal disorders. Chicory was among the plants with potential against SARS-CoV-2, too. To this and other ends, roots, herb, flowers and leaves are used. Apart from its phytochemical applications, chicory is also used in gastronomy as a coffee substitute, food or drink additive. The aim of this paper is to present, in the light of the recent literature, the chemical composition and properties of chicory.

1 April 2015 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MMMichał Moritz
Michał Moritz
MGMałgorzata Geszke-Moritz
Małgorzata Geszke-Moritz

1 April 2013 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MGMałgorzata Geszke-Moritz
Małgorzata Geszke-Moritz
MMMichał Moritz
Michał Moritz